Rational Incorporation of Selenium into Temozolomide Elicits Superior Antitumor Activity Associated with Both Apoptotic and Autophagic Cell Death

BACKGROUND: The DNA alkylating agent temozolomide (TMZ) is widely used in the treatment of human malignancies such as glioma and melanoma. On the basis of previous structure-activity studies, we recently synthesized a new TMZ selenium analog by rationally introducing an N-ethylselenocyanate extensio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cheng, Yan, Sk, Ugir Hossain, Zhang, Yi, Ren, Xingcong, Zhang, Li, Huber-Keener, Kathryn J., Sun, Yuan-Wan, Liao, Jason, Amin, Shantu, Sharma, Arun K., Yang, Jin-Ming
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3320619/
https://ncbi.nlm.nih.gov/pubmed/22496897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0035104
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars